Drug intelligence / Profile preview

PP005

Development stage: Preclinical
Lead developer: Plano
Modality: Small Molecules
Administration: Intravenous

Overview

PP005 is a generic sterile injectable anesthetic candidate under development by Plano Pharmaceuticals. It is part of a pipeline specifically designed to address drug shortages in the North American market. While the specific active pharmaceutical ingredient (API) has not been publicly disclosed, the product is categorized as an anesthetic intended for sterile injectable administration. The development of PP005 is currently ongoing, aimed at providing a reliable supply of essential anesthetic medications.

Other names: Influenza vaccine inhalable protein

Beyond the preview

Go deeper on PP005.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PP005.

Explore the full profile